Search Within

Hematologic Malignancies, Division of

  1. "Leukemia Research"
Formats
  1. Journal Article (59)
  2. Meeting Abstract (16)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (77)
  2. Center for Hematologic Malignancies (65)
  3. Adult Leukemia (52)
  4. GSK Faculty (21)
  5. Epidemiology and Biostatistics (19)
  6. Biostatistics Service (17)

More Groups

People
  1. Martin Tallman (27)
  2. Virginia Klimek (10)
  3. Omar Abdel-Wahab (9)
  4. Eytan Stein (8)
  5. Sean Devlin (8)
  6. Stephen Nimer (8)

More People

Years
  1. 2025 (1)
  2. 2023 (4)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (4)

More Years

Publications
  1. Leukemia Research (77)
Publishers
  1. Elsevier Ltd (76)
  2. Elsevier Inc. (1)

Results (77)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • New treatments for adult T-cell leukemia/lymphoma
    Review

    Epstein-Peterson, Z. D.; Gurumurthi, A.; Horwitz, S. M.
    Leukemia Research (2025)

    Fulltext@MSK | Save
  • Ultra-low input sequencing to identifies transplant resistant stem cells in myelodysplastic syndromes
    Meeting Abstract

    Kroger, B.; Huang, Y.; Patel, P.; Afrough, A.; Kaur, G.; Anderson, L.; Awan, F.; Ramakrishnan, P.; Verma, K.; Vittrup, R.; more...
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Pevaz: A phase II study of pevonedistat and azacitidine in MDS and MDS/MPN patients relapsed or refractory to DNMT inhibition (DNMTI)
    Meeting Abstract

    Watts, J.; Smith, B.; Bradley, T.; Skikne, B.; Mendler, J.; Klimek, V.; Thomassen, A.; Stopcyzinski, T.; Chen, S. C.; Run, F.; more...
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Targeting the spliceosome
    Meeting Abstract

    Abdel-Wahab, O.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
    Journal Article

    Atchley, E.; Weis, T. M.; Derkach, A.; Galera, P. K.; Xiao, W.; Glass, J.; DeWolf, S.; Roshal, M.; Shah, R.; Stump, S. E.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis
    Research Letter

    King, A. C.; Derkach, A.; Weis, T. M.; Stump, S. E.; Ciervo, J. R.; Ranaghan, C. P.; Stein, E. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia
    Journal Article

    Parisi, R.; Cowen, E. A.; Stoll, J. R.; Zhu, H.; Dusza, S.; Pulitzer, M. P.; Stein, E. M.; Markova, A.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
    Journal Article

    Ganzel, C.; Sun, Z.; Baslan, T.; Zhang, Y.; Gönen, M.; Abdel-Wahab, O. I.; Racevskis, J.; Garrett-Bakelman, F.; Lowe, S. W.; Fernandez, H. F.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features
    Journal Article

    Epstein-Peterson, Z. D.; Spitzer, B.; Derkach, A.; Arango, J. E.; McCarter, J. G. W.; Medina-Martínez, J. S.; McGovern, E.; Farnoud, N. R.; Levine, R. L.; Tallman, M. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save